Related Experiment Video
Updated: Jul 6, 2025
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Proteomics: A new dimension to decode small cell lung cancer
Haobin Chen1, Benjamin J Drapkin2, John D Minna2
1Division of Oncology, Department of Medicine, Washington University in Saint Louis, St Louis, MO, USA.
Researchers mapped the proteomic and phosphoproteomic features of small cell lung cancer (SCLC) tumors. This detailed biological insight reveals new potential vulnerabilities for treating this challenging cancer.
Area of Science:
- Oncology
- Molecular Biology
- Proteomics
Background:
- Small cell lung cancer (SCLC) remains a difficult-to-treat malignancy.
- Understanding the molecular underpinnings of SCLC is crucial for developing effective therapies.
Purpose of the Study:
- To comprehensively analyze the proteomic and phosphoproteomic profiles of resected SCLC tumors.
- To identify novel molecular vulnerabilities in SCLC based on proteomic data.
Main Methods:
- Proteomic analysis of SCLC tumor samples.
- Phosphoproteomic analysis of SCLC tumor samples.
Main Results:
- Detailed proteomic and phosphoproteomic landscapes of SCLC tumors were generated.
- The study identified specific molecular targets and pathways associated with SCLC.
Conclusions:
- The proteomic and phosphoproteomic data provide a valuable resource for SCLC research.
- This knowledge can guide the development of new therapeutic strategies targeting identified SCLC vulnerabilities.
More Related Videos
10:37Deep Proteome Profiling by Isobaric Labeling, Extensive Liquid Chromatography, Mass Spectrometry, and Software-assisted Quantification
Published on: November 15, 2017
12:23Phosphopeptide Enrichment Coupled with Label-free Quantitative Mass Spectrometry to Investigate the Phosphoproteome in Prostate Cancer
Published on: August 2, 2018
